XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
CURRENT ASSETS    
Cash and cash equivalents $ 403 $ 496
Trade receivables 192 216
Inventories 70 72
Assets held for sale 13 13
Receivable from affiliate 66 19
Other current assets, net 95 113
Total current assets 839 929
PROPERTY, PLANT AND EQUIPMENT 3,514 3,437
Accumulated depreciation, depletion and amortization (721) (667)
Total property, plant and equipment, net 2,793 2,770
INVESTMENT IN UNCONSOLIDATED SUBSIDIARY 16 19
DEFERRED INCOME TAXES 139 132
OTHER NONCURRENT ASSETS 123 148
TOTAL ASSETS 3,910 3,998
CURRENT LIABILITIES    
Accounts payable 251 245
Liabilities associated with assets held for sale 5 5
Accrued liabilities 338 366
Total current liabilities 594 616
NONCURRENT LIABILITIES    
Long-term debt, net 541 540
Asset retirement obligations 429 422
Other long-term liabilities 253 201
STOCKHOLDERS' EQUITY    
Preferred stock (20,000,000 shares authorized at $0.01 par value) no shares outstanding at March 31, 2024 and December 31, 2023 0 0
Common stock (200,000,000 shares authorized at $0.01 par value) (84,460,423 and 83,557,800 shares issued; 68,530,744 and 68,693,885 shares outstanding at March 31, 2024 and December 31, 2023) 1 1
Treasury stock (15,929,679 shares held at cost at March 31, 2024 and 14,863,915 shares held at cost at December 31, 2023) (662) (604)
Additional paid-in capital 1,295 1,329
Retained earnings 1,387 1,419
Accumulated other comprehensive income 72 74
Total stockholders' equity 2,093 2,219
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,910 $ 3,998